ميمپارا

Land: Israël

Taal: Arabisch

Bron: Ministry of Health

Werkstoffen:

CINACALCET HYDROCHLORIDE 30 MG

Beschikbaar vanaf:

AMGEN EUROPE B.V.

ATC-code:

H05BX01

farmaceutische vorm:

FILM COATED TABLETS

Toedieningsweg:

PER OS

Geproduceerd door:

AMGEN EUROPE B.V., NETHERLANDS

Therapeutische categorie:

CINACALCET

therapeutische indicaties:

Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.

Autorisatie datum:

2012-10-01